Literature DB >> 8621729

Selective activation of MEK1 but not MEK2 by A-Raf from epidermal growth factor-stimulated Hela cells.

X Wu1, S J Noh, G Zhou, J E Dixon, K L Guan.   

Abstract

Activation of the mitogen-activated protein kinase cascade is a critical event in mitogenic growth factor signal transduction. Mitogen-activated protein kinase is directly activated by a dual specific kinase, MEK, which itself is activated by serine phosphorylation. The c-Raf kinase has been implicated in mediating the signal transduction from mitogenic growth factor receptors to MEK activation. Recently, the B-Raf kinase was shown to be capable of phosphorylating and activating MEK as a result of growth factor stimulation. In this report, we used the yeast two-hybrid screening to isolate MEK interacting proteins. All three members of the Raf family kinases were identified as positive clones when the mutant MEK1S218/222A, in which the two phosphorylation serine residues were substituted by alanines, was used as a bait, whereas no positive clones were isolated when the wild type MEK1 was used as a bait in a similar screening. These results suggest that elimination of the phosphorylation sites of a target protein (MEK1 in our study) may stabilize the interaction between the kinase (Raf) and its substrate (MEK1), possibly due the formation of a nonproductive complex. These observations seem to suggest a general strategy using mutants to identify the upstream kinase of a phosphoprotein or the downstream targets of a kinase. Although c-Raf and B-Raf have been implicated in growth factor-induced MEK activation, little is known about A-Raf. We observed that stimulation of Hela cells with epidermal growth factor resulted in a rapid and transient activation of A-Raf, which is then capable of phosphorylating and activating MEK1. Interestingly, A-Raf does not activate MEK2, although c-Raf can activate both MEK1 and MEK2. Our data demonstrated that A-Raf is, indeed, a MEK1 activator and may play a role in growth factor signaling.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621729     DOI: 10.1074/jbc.271.6.3265

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  Mitogen-activated protein kinases: specific messages from ubiquitous messengers.

Authors:  H J Schaeffer; M J Weber
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  Identification of TH1 as an interaction partner of A-Raf kinase.

Authors:  Xiang L Yin; She Chen; Jian X Gu
Journal:  Mol Cell Biochem       Date:  2002-02       Impact factor: 3.396

3.  Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate.

Authors:  Pablo Rodriguez-Viciana; Celine Sabatier; Frank McCormick
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

4.  Cortical migration defects in mice expressing A-RAF from the B-RAF locus.

Authors:  Guadalupe Camarero; Oleg Yu Tyrsin; Chaomei Xiang; Verena Pfeiffer; Sandra Pleiser; Stefan Wiese; Rudolf Götz; Ulf R Rapp
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

5.  Activation of c-Raf-1 by Ras and Src through different mechanisms: activation in vivo and in vitro.

Authors:  D Stokoe; F McCormick
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

Review 6.  PP2A as a master regulator of the cell cycle.

Authors:  Nathan Wlodarchak; Yongna Xing
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-02-24       Impact factor: 8.250

7.  Cyclic AMP selectively uncouples mitogen-activated protein kinase cascades from activating signals.

Authors:  Gray W Pearson; Svetlana Earnest; Melanie H Cobb
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

8.  Mek2 is dispensable for mouse growth and development.

Authors:  Louis-François Bélanger; Sophie Roy; Michel Tremblay; Barbara Brott; Ann-Muriel Steff; Walid Mourad; Patrice Hugo; Raymond Erikson; Jean Charron
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

Review 9.  From basic research to clinical development of MEK1/2 inhibitors for cancer therapy.

Authors:  Christophe Frémin; Sylvain Meloche
Journal:  J Hematol Oncol       Date:  2010-02-11       Impact factor: 17.388

10.  Growth arrest signaling of the Raf/MEK/ERK pathway in cancer.

Authors:  Jong-In Park
Journal:  Front Biol (Beijing)       Date:  2014-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.